title: [Rapid release fentanyl administration forms. Comments of the Working Group on Tumor Pain of the German Pain Society].
abstract: The spectrum of indications for rapid release fentanyl preparations is controversial. For this reason the Working Group on Tumor Pain will formulate comments on how to deal with these substances. Breakthrough pain should receive individualized therapy; therefore, the use of opioids of various galenic formulations seems to be advisable. New rapid release fentanyl preparations are suitable for alleviating spontaneous breakthrough pain in tumor patients due to a rapid but short-acting effect. However, a prior optimization of the analgesic basis medication is absolutely necessary. Uncontrolled prescription for non-cancer pain must be criticized due to the problem of addiction. The medical profession should be informed about the benefits of rapid release fentanyl preparations but must also be made aware of the risk of a rapid development of addiction and tolerance. A self-commitment of the pharmaceutical industry to waive advertising for the dangerous off-label use would be desirable. In the opinion of the Working Group on Tumor Pain the use of fentanyl should be openly discussed and further scientific investigations are imperative with the aim of formulating clear recommendations.
authors: Abteilung für Anästhesie, Interdisziplinäre Intensivmedizin, Schmerztherapie, Palliativmedizin, CURA Kath. Krankenhaus im Siebengebirge, Schülgenstr. 15, 53604, Bad Honnef, Deutschland. stefan.wirz@cura.org
authors: S
authors: S
authors: Wirz
authors: C H R
authors: CH
authors: Wiese
authors: M
authors: M
authors: Zimmermann
authors: U
authors: U
authors: Junker
authors: E
authors: E
authors: Heuser-Grannemann
authors: M
authors: M
authors: Schenk
mesh_terms: D000329:Advertising; D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D059390:Breakthrough Pain / Q000097:blood / Q000188:drug therapy*; D004345:Drug Industry; D004361:Drug Tolerance; D004493:Education; D005283:Fentanyl / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D005858:Germany; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology*; D056687:Off-Label Use; D009293:Opioid-Related Disorders / Q000209:etiology* / Q000517:prevention & control; D012307:Risk Factors; D012955:Societies, Medical
chemical_list: D000701:Analgesics, Opioid; D005283:Fentanyl
references: Int J Clin Pharmacol Ther. 2010 Dec;48(12):860-7
references: 21084042
references: J Pain Palliat Care Pharmacother. 2008;22(1):47
references: 19062355
references: Pain. 2010 Dec;151(3):617-624
references: 20800358
references: Curr Med Res Opin. 2009 Nov;25(11):2805-15
references: 19792837
references: Eur J Pain. 2009 Apr;13(4):331-8
references: 18707904
references: Pain. 2001 Mar;91(1-2):123-30
references: 11240084
references: Curr Med Res Opin. 2009 Dec;25(12):2877-85
references: 19814586
references: Pain Med. 2008 Mar;9(2):258-60; author reply 261-5
references: 18298711
references: J Pain Symptom Manage. 1999 Jun;17(6):391-401
references: 10388244
references: Pain. 2008 Jun;136(3):227-229
references: 18384960
references: Schmerz. 1993 Sep;7(3):174-7
references: 18415403
references: J Pain Symptom Manage. 1996 Jul;12(1):3-10
references: 8718910
references: Anaesthesist. 2011 Jul;60(7):674-82
references: 21491140
references: Pharmacopsychiatry. 2004 Jul;37(4):191-2
references: 15467978
references: J Addict Dis. 2006;25(4):139-40; discussion 141-4
references: 17088236
references: J Pain Symptom Manage. 2000 Aug;20(2):87-92
references: 10989246
references: Lancet Oncol. 2012 Feb;13(2):e58-68
references: 22300860
references: Ann Oncol. 2009 Aug;20(8):1420-33
references: 19244085
references: Pain. 1991 Apr;45(1):107
references: 1861874
references: Clin Ther. 2009 Jun;31(6):1177-91
references: 19695386
references: Drug Alcohol Depend. 1978 Nov;3(6):383-91
references: 720208
references: Pain. 1990 Jun;41(3):273-281
references: 1697056
references: Cancer. 2002 Feb 1;94(3):832-9
references: 11857319
references: Pain. 1999 May;81(1-2):129-34
references: 10353500
references: Schmerz. 2007 Aug;21(4):359-70; quiz 371-2
references: 17684772
references: Pain Med. 2001 Mar;2(1):15-23
references: 15102313
references: Schmerz. 2010 Dec;24(6):605-12
references: 21046170
references: Schmerz. 2007 Nov;21(6):545-52
references: 17899213
references: Schmerz. 2001 Aug;15(4):241-7
references: 11810362
references: Eur J Pain. 2005 Apr;9(2):195-206
references: 15737812
references: J Pain Symptom Manage. 2008 May;35(5):563-7
references: 18258412